Conflicting results regarding the effect of ADRB2 variants across different studies may be related to several factors, such as different therapeutic approaches to asthma at different locations, and use of different criteria for asthma diagnosis and allocation of subjects to referral services, which lead to non-random allocation of patients with different degrees of asthma severity, among others.(25). This evidence concerns the gene ADRB2 and asthma.